Innate immunity and the role of defensins in otitis media

Current Allergy and Asthma Reports

Volumn 11, Issue 6, 2011, Pages 499-507

  Underwood, Mark ^a   Bakaletz, Lauren ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial peptide; Defensin; Innate immunity; Otitis; Otitis media; Pathogenesis

Indexed keywords

ALPHA DEFENSIN; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIOCIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; GENTAMICIN; HALOCIDIN; LECTIN; LYSOZYME; MESSENGER RNA; OFLOXACIN; PEPTIDE ST4SA; POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT PROTEIN; SPLUNC1 PROTEIN; UNCLASSIFIED DRUG; XYLITOL;

ACUTE OTITIS MEDIA; ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; BACTERIAL GENE; BETA DEFENSIN 1 GENE; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENTAL CARIES; DRUG EFFECT; DRUG MECHANISM; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NONHUMAN; OPERON; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT INFECTION; REVIEW; SENSITIVITY TO ANTIMICROBIAL PEPTIDE GENE; SIGNAL TRANSDUCTION;

DEFENSINS; EAR, MIDDLE; HUMANS; IMMUNITY, INNATE; OTITIS MEDIA;

EID: 81155130857     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-011-0223-6     Document Type: Review

References (73)

1. PS Taylor I Faeth MK Marks CB Del Mar SA Skull ML Pezzullo SM Havyatt HL Coates 2009 Cost of treating otitis media in Australia Expert Rev Pharmacoecon Outcomes Res 9 133 141 19402800 10.1586/erp.09.6
2. PC Coyte CV Asche LM Elden 1999 The economic cost of otitis media in Canada Int J Pediatr Otorhinolaryngol 49 27 36 10428403 10.1016/S0165-5876(99) 00041-5 1:STN:280:DyaK1MzlsFemtQ%3D%3D (Pubitemid 29295683)
3. MA O'Brien LA Prosser JL Paradise GT Ray M Kulldorff M Kurs-Lasky VL Hinrichsen J Mehta DK Colborn TA Lieu 2009 New vaccines against otitis media: projected benefits and cost-effectiveness Pediatrics 123 1452 1463 19482754 10.1542/peds.2008-1482
4. SU Kalu RS Ataya DP McCormick JA Patel K Revai T Chonmaitree 2011 Clinical spectrum of acute otitis media complicating upper respiratory tract viral infection Pediatr Infect Dis J 30 95 99 20711085 10.1097/INF. 0b013e3181f253d5
5. JC Post NL Hiller L Nistico P Stoodley GD Ehrlich 2007 The role of biofilms in otolaryngologic infections: update 2007 Curr Opin Otolaryngol Head Neck Surg 15 347 351 17823552 10.1097/MOO.0b013e3282b97327 (Pubitemid 47373982)
6. M Hoa M Syamal MA Schaeffer L Sachdeva R Berk J Coticchia 2010 Biofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis media Am J Otolaryngol 31 241 245 20015753 10.1016/j.amjoto.2009.02.015 Analysis of biofilms on adenoidal tissue removed from children with recurrent OM, OM with effusion, and sleep apnea showed marked differences. Biofilm formation was extensive in recurrent OM, moderate in OM with effusion, and minimal in sleep apnea. This suggests a significant role of biofilms in recurrent OM
7. TF Murphy LO Bakaletz PR Smeesters 2009 Microbial interactions in the respiratory tract Pediatr Infect Dis J 28 S121 S126 19918134 10.1097/INF.0b013e3181b6d7ec This article summarizes the interactions and competition between the major pathogens of OM and the importance of biofilm formation in chronic OM
8. K Revai DP McCormick J Patel JJ Grady K Saeed T Chonmaitree 2006 Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media Pediatrics 117 1823 1829 16651345 10.1542/peds.2005- 1983 (Pubitemid 46071418)
9. R Kaur DG Adlowitz JR Casey M Zeng ME Pichichero 2010 Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media Pediatr Infect Dis J 29 741 745 20335823 10.1097/INF.0b013e3181d9e639
10. T De Baere M Vaneechoutte P Deschaght J Huyghe I Dhooge 2010 The prevalence of middle ear pathogens in the outer ear canal and the nasopharyngeal cavity of healthy young adults Clin Microbiol Infect 16 1031 1035 19895585
11. J Paluch-Oles A Magrys M Koziol-Montewka A Niedzielski J Niedzwiadek G Niedzielska M Kotowski 2010 The phenotypic and genetic biofilm formation characteristics of coagulase-negative staphylococci isolates in children with otitis media Int J Pediatr Otorhinolaryngol 75 126 130 21093067 10.1016/j.ijporl.2010.10.025
12. C Kaji K Watanabe MA Apicella H Watanabe 2008 Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms Tohoku J Exp Med 214 121 128 18285669 10.1620/tjem.214.121 1:CAS:528:DC%2BD1cXjs1emsrw%3D (Pubitemid 351513544)
13. SK Lee MS Lee SY Jung JY Byun MS Park SG Yeo 2010 Antimicrobial resistance of Pseudomonas aeruginosa from otorrhea of chronic suppurative otitis media patients Otolaryngol Head Neck Surg 143 500 505 20869558 10.1016/j.otohns.2010.06.906
14. HJ Shim CH Park MG Kim SK Lee SG Yeo 2010 A pre- and postoperative bacteriological study of chronic suppurative otitis media Infection 38 447 452 20700754 10.1007/s15010-010-0048-6 1:STN:280:DC%2BC3M%2FivV2isA%3D%3D This was a survey of the microbiota in chronic suppurative otitis before and after surgery. The major organisms were S. aureus, coagulase-negative staphylococci, and P. aeruginosa, with the latter most likely to persist after surgery
15. F Ricciardiello M Cavaliere M Mesolella M Iengo 2009 Notes on the microbiology of cholesteatoma: clinical findings and treatment Acta Otorhinolaryngol Ital 29 197 202 20161877 1:STN:280:DC%2BC3c7ht1yisA%3D%3D
16. American Academy of Pediatrics SoMoAOM 2004 Diagnosis and management of acute otitis media Pediatrics 113 1451 1465 10.1542/peds.113.5.1451 (Pubitemid 38580721)
17. American Academy of Pediatrics SoOMwE 2004 Otitis media with effusion Pediatrics 113 1412 1429 10.1542/peds.113.5.1412 (Pubitemid 38584578)
18. A Coco L Vernacchio M Horst A Anderson 2010 Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline Pediatrics 125 214 220 20100746 10.1542/peds.2009-1115 This was a comparison of treatment of otitis in the United States for the 30 months before and the 30 months after publication of the 2004 guidelines. There was no significant change in the number of patients with otitis who were not treated with antibiotics, but there was an increase in use of amoxicillin and a decrease in use of amoxicillin-clavulanate
19. A Vergison R Dagan A Arguedas J Bonhoeffer R Cohen I Dhooge A Hoberman J Liese P Marchisio AA Palmu GT Ray EA Sanders EA Simoes M Uhari J van Eldere SI Pelton 2010 Otitis media and its consequences: beyond the earache Lancet Infect Dis 10 195 203 20185098 10.1016/S1473-3099(10)70012-8
20. A Leichtle Y Lai B Wollenberg SI Wasserman AF Ryan 2011 Innate signaling in otitis media: pathogenesis and recovery Curr Allergy Asthma Rep 11 78 84 21049294 10.1007/s11882-010-0158-3
21. M Hernandez A Leichtle K Pak J Ebmeyer S Euteneuer M Obonyo DG Guiney NJ Webster DH Broide AF Ryan SI Wasserman 2008 Myeloid differentiation primary response gene 88 is required for the resolution of otitis media J Infect Dis 198 1862 1869 18986247 10.1086/593213
22. A Leichtle M Hernandez K Pak K Yamasaki CF Cheng NJ Webster AF Ryan SI Wasserman 2009 TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media Innate Immun 15 205 215 19586996 10.1177/1753425909103170 1:CAS:528:DC%2BD1MXhtVyiur%2FJ This article describes inflammatory responses to NTHI in wild-type, TLR2 knockout, and TLR4 knockout mice. Both knockout groups demonstrated decreased tumor necrosis factor induction, delayed bacterial clearance, and persistent inflammation compared with wild-type mice. TLR2 induction was decreased in the TLR4 knockouts, suggesting that TLR4 induces TLR2 expression; both receptors are important in the immune response to NTHI
23. •• Leichtle A, Hernandez M, Lee J, Pak K, Webster NJ, Wollenberg B, et al. The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun. 2011. TLR9 senses bacterial DNA. TLR9 knockout mice demonstrate delayed bacterial clearance and persistent inflammation after middle ear infection with NTHI compared with wild-type mice. TLR9 is also important in the immune response to NTHI.
24. AB Dalia AJ Standish JN Weiser 2010 Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils Infect Immun 78 2108 2116 20160017 10.1128/IAI.01125-09 1:CAS:528:DC%2BC3cXlsFKnsro%3D
25. RA Juneau B Pang KE Weimer CE Armbruster WE Swords 2011 Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps Infect Immun 79 431 438 20956567 10.1128/IAI.00660-10 1:CAS:528: DC%2BC3MXisVegurY%3D
26. T Hirano S Kodama M Moriyama T Kawano M Suzuki 2009 The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein Int J Pediatr Otorhinolaryngol 73 1657 1665 19765832 10.1016/j.ijporl.2009.08.015 Outer membrane proteins of NTHI are promising vaccine candidates. Comparison of mucosal and systemic immune responses to intranasal instillation of NTHI outer membrane proteins in wild-type and TLR4 knockout mice demonstrated the importance of the TLR4 receptor in response to this potential vaccine
27. N Takahashi T Yamada N Narita S Fujieda 2006 Double-stranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts Clin Immunol 118 51 58 16253565 10.1016/j.clim.2005.09.001 1:CAS:528:DC%2BD2MXhtlGlsr7L (Pubitemid 43012046)
28. BG Oliver SL Johnston M Baraket JK Burgess NJ King M Roth S Lim JL Black 2006 Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection Respir Res 7 71 16670028 10.1186/1465-9921-7-71 (Pubitemid 44202723)
29. Nonaka M, Ogihara N, Fukumoto A, Sakanushi A, Pawankar R, Yagi T. Poly(I:C) synergizes with Th2 cytokines to induce TARC/CCL17 in middle ear fibroblasts established from mucosa of otitis media with effusion. Acta Otolaryngol Suppl. 2009;57-62.
30. NH Salzman K Hung D Haribhai H Chu J Karlsson-Sjoberg E Amir P Teggatz M Barman M Hayward D Eastwood M Stoel Y Zhou E Sodergren GM Weinstock CL Bevins CB Williams NA Bos 2010 Enteric defensins are essential regulators of intestinal microbial ecology Nat Immunol 11 76 83 19855381 10.1038/ni.1825 1:CAS:528:DC%2BD1MXhtlSqsbzF
31. NH Salzman MA Underwood CL Bevins 2007 Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa Semin Immunol 19 70 83 17485224 10.1016/j.smim.2007.04.002 1:CAS:528:DC%2BD2sXmtVOksrs%3D (Pubitemid 46824070)
32. T Ganz 2003 Defensins: antimicrobial peptides of innate immunity Nat Rev Immunol 3 710 720 12949495 10.1038/nri1180 1:CAS:528:DC%2BD3sXmvVWmtLc%3D (Pubitemid 41070812)
33. RI Lehrer 2004 Primate defensins Nat Rev Microbiol 2 727 738 15372083 10.1038/nrmicro976 1:CAS:528:DC%2BD2cXnt1CntLk%3D (Pubitemid 39200064)
34. M Zasloff 2002 Antimicrobial peptides of multicellular organisms Nature 415 389 395 11807545 10.1038/415389a 1:CAS:528:DC%2BD38XhtVCgsLs%3D (Pubitemid 34100944)
35. RI Lehrer G Jung P Ruchala W Wang ED Micewicz AJ Waring EJ Gillespie KA Bradley AJ Ratner RF Rest W Lu 2009 Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins Infect Immun 77 4028 4040 19581399 10.1128/IAI.00232-09 1:CAS:528:DC%2BD1MXhtFehtr%2FP
36. D Yang ZH Liu P Tewary Q Chen G de la Rosa JJ Oppenheim 2007 Defensin participation in innate and adaptive immunity Curr Pharm Des 13 3131 3139 17979754 10.2174/138161207782110453 1:CAS:528:DC%2BD2sXhtlarurnL (Pubitemid 350130962)
37. LO Bakaletz 2009 Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention Expert Rev Vaccines 8 1063 1082 19627188 10.1586/erv.09.63 This article presents a description of the chinchilla as the gold standard for polymicrobial OM
38. RH Harris D Wilk CL Bevins RS Munson Jr LO Bakaletz 2004 Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway J Biol Chem 279 20250 20256 14996845 10.1074/jbc.M400499200 1:CAS:528:DC%2BD2cXjs1Whur4%3D (Pubitemid 38623470)
39. G McGillivary WC Ray CL Bevins RS Munson Jr LO Bakaletz 2007 A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media Mol Immunol 44 2446 2458 17113647 10.1016/j.molimm.2006.10.008 1:CAS:528:DC%2BD2sXntVKnsQ%3D%3D (Pubitemid 46097098)
40. G McGillivary KM Mason JA Jurcisek ME Peeples LO Bakaletz 2009 Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae Cell Microbiol 11 1399 1408 19500108 10.1111/j.1462-5822. 2009.01339.x 1:CAS:528:DC%2BD1MXhtFSgurvP This study demonstrated an important mechanism underlying polymicrobial OM. Infection with RSV inhibits chinchilla β-defensin expression, thereby allowing NTHI to flourish
41. D Jin Shin S Gan-Undram S Jin Kim Y Joon Jun G Jung Im H Hyun Jung 2006 Expression of beta-defensins in the tubotympanum of experimental otitis media Acta Otolaryngol 126 1040 1045 16923707 10.1080/00016480600672626 (Pubitemid 44272827)
42. Y Jiang Y Wang B Wang D Yang K Yu X Yang F Liu Z Jiang M Li 2010 Antifungal activity of recombinant mouse beta-defensin 3 Lett Appl Microbiol 50 468 473 20337925 10.1111/j.1472-765X.2010.02824.x 1:CAS:528:DC%2BC3cXms1OlsLY%3D
43. T Gong Y Jiang Y Wang D Yang W Li Q Zhang W Feng B Wang Z Jiang M Li 2010 Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry Arch Virol 155 491 498 20195655 10.1007/s00705-010-0608-1 1:CAS:528:DC%2BC3cXktVSns7s%3D Mouse β-defensin 2 has strong antiviral activity against influenza A and is protective in mice when administered before or immediately after a lethal dose of influenza A
44. HY Lee A Andalibi P Webster SK Moon K Teufert SH Kang JD Li M Nagura T Ganz DJ Lim 2004 Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae BMC Infect Dis 4 12 15125783 10.1186/1471-2334-4-12 (Pubitemid 39637313)
45. SK Moon HY Lee H Pan T Takeshita R Park K Cha A Andalibi DJ Lim 2006 Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells BMC Infect Dis 6 12 16433908 10.1186/1471-2334-6-12 (Pubitemid 43264313)
46. HY Lee T Takeshita J Shimada A Akopyan JI Woo H Pan SK Moon A Andalibi RK Park SH Kang SS Kang R Gellibolian DJ Lim 2008 Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells BMC Infect Dis 8 87 18578886 10.1186/1471-2334-8-87 (Pubitemid 352024887)
47. SL Bishop-Hurley FJ Schmidt AL Erwin AL Smith 2005 Peptides selected for binding to a virulent strain of Haemophilus influenzae by phage display are bactericidal Antimicrob Agents Chemother 49 2972 2978 15980377 10.1128/AAC.49.7.2972-2978.2005 1:CAS:528:DC%2BD2MXlvFSlsb8%3D (Pubitemid 40917619)
48. G Alzbutiene A Hermansson P Caye-Thomasen V Kinduris 2008 Tympanic membrane changes in experimental acute otitis media and myringotomy Medicina (Kaunas) 44 313 321
49. MJ Vonk PS Hiemstra JJ Grote 2008 An antimicrobial peptide modulates epithelial responses to bacterial products Laryngoscope 118 816 820 18300705 10.1097/MLG.0b013e31816422d7 1:CAS:528:DC%2BD1cXltlSmsLk%3D (Pubitemid 351631284)
50. J Shimada SK Moon HY Lee T Takeshita H Pan JI Woo R Gellibolian N Yamanaka DJ Lim 2008 Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media BMC Infect Dis 8 134 18842154 10.1186/1471-2334-8-134
51. PA Wescombe NC Heng JP Burton CN Chilcott JR Tagg 2009 Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics Future Microbiol 4 819 835 19722837 10.2217/fmb.09.61 1:CAS:528: DC%2BD1MXhtVygsrrM This article describes the diverse bacteriocins produced by streptococci. Special emphasis is placed on a promising commensal strain that produces broad-spectrum bacteriocins
52. K Roos EG Hakansson S Holm 2001 Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial BMJ 322 210 212 11159619 10.1136/bmj.322.7280.210 1:STN:280:DC%2BD3M7ktF2qtQ%3D%3D (Pubitemid 32116166)
53. I Brook 2005 The role of bacterial interference in otitis, sinusitis and tonsillitis Otolaryngol Head Neck Surg 133 139 146 16025067 10.1016/j.otohns. 2005.03.012 (Pubitemid 40980976)
54. H Knoetze SD Todorov LM Dicks 2008 A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media Int J Antimicrob Agents 31 228 234 18155886 10.1016/j.ijantimicag.2007.10.010 1:CAS:528: DC%2BD1cXitVOktbk%3D
55. CH Jang YB Cho SE Oh JU Choi H Park CH Choi 2010 Effect of nebulized bovine surfactant for experimental otitis media with effusion Clin Exp Otorhinolaryngol 3 13 17 20379396 10.3342/ceo.2010.3.1.13 This article explores the novel approach of using nebulized bovine surfactant to reduce eustachian tube opening pressure in a guinea pig model of OM with effusion
56. G McGillivary LO Bakaletz 2010 The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway PLoS One 5 e13224 20949060 10.1371/journal.pone.0013224 This study demonstrated the role of the antimicrobial peptide SLPUNC1 in maintaining efficient mucociliary middle ear clearance in the chinchilla model of OM
57. WS Jang KN Kim YS Lee MH Nam IH Lee 2002 Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium FEBS Lett 521 81 86 12067731 10.1016/S0014-5793(02)02827-2 1:CAS:528:DC%2BD38XksVaiu7s%3D (Pubitemid 34628463)
58. YS Lee YJ Kim SH Choi KH Shin WS Jang IH Lee JW Chung 2010 Di-K19Hc, an antimicrobial peptide as new ototopical agent for treatment of otitis media Acta Otolaryngol 130 897 903 20100130 10.3109/00016480903536036 1:CAS:528: DC%2BC3cXoslyltLw%3D This study demonstrated strong antibacterial activity of a synthetic halocidin against multiple drug-resistant strains of P. aeruginosa and methicillin-resistant S. aureus.
59. P Kurola T Tapiainen J Sevander T Kaijalainen M Leinonen M Uhari A Saukkoriipi 2010 Effect of xylitol and other carbon sources on Streptococcus pneumoniae biofilm formation and gene expression in vitro APMIS 119 135 142 21208281 10.1111/j.1600-0463.2010.02703.x Twenty pneumococcal isolates obtained from middle ear aspirates were grown in culture media containing xylitol, glucose, fructose, or combinations of these sugars. Xylitol inhibited bacterial growth and biofilm formation, but glucose and fructose (alone or added to xylitol) had the opposite effect.
60. M Uhari T Kontiokari M Niemela 1998 A novel use of xylitol sugar in preventing acute otitis media Pediatrics 102 879 884 9755259 10.1542/peds.102.4.879 1:STN:280:DyaK1cvivFKjug%3D%3D (Pubitemid 28462528)
61. T Taipale K Pienihakkinen P Alanen J Jokela E Soderling 2007 Dissolution of xylitol from a food supplement administered with a novel slow-release pacifier: preliminary results Eur Arch Paediatr Dent 8 123 125 17555696 1:STN:280:DC%2BD2szkt12qug%3D%3D
62. KM Mason RS Munson Jr LO Bakaletz 2005 A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media Infect Immun 73 599 608 15618200 10.1128/IAI.73.1.599-608.2005 1:CAS:528:DC%2BD2MXisFyqsw%3D%3D (Pubitemid 40041155)
63. KM Mason ME Bruggeman RS Munson LO Bakaletz 2006 The non-typeable Haemophilus influenzae Sap transporter provides a mechanism of antimicrobial peptide resistance and SapD-dependent potassium acquisition Mol Microbiol 62 1357 1372 17064364 10.1111/j.1365-2958.2006.05460.x 1:CAS:528:DC%2BD28Xhtlenu7nE (Pubitemid 44707199)
64. H Roy K Dare M Ibba 2009 Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids Mol Microbiol 71 547 550 19054327 10.1111/j.1365-2958.2008.06563.x 1:CAS:528:DC%2BD1MXisFCqsbo%3D
65. M Haggard 2011 Poor adherence to antibiotic prescribing guidelines in acute otitis media-obstacles, implications, and possible solutions Eur J Pediatr 170 323 332 20862492 10.1007/s00431-010-1286-4 This article reviews treatment guidelines from several organizations, barriers to compliance with these guidelines, and recommendations for improvement
66. TF Murphy 2005 Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges Expert Rev Vaccines 4 843 853 16372880 10.1586/14760584.4.6.843 1:CAS:528: DC%2BD28Xpt1Cgtw%3D%3D (Pubitemid 43040905)
67. B Ericksen Z Wu W Lu RI Lehrer 2005 Antibacterial activity and specificity of the six human {alpha}-defensins Antimicrob Agents Chemother 49 269 275 15616305 10.1128/AAC.49.1.269-275.2005 1:CAS:528:DC%2BD2MXjvVShsQ%3D%3D (Pubitemid 40065802)
68. O Soehnlein Y Kai-Larsen R Frithiof OE Sorensen E Kenne K Scharffetter-Kochanek EE Eriksson H Herwald B Agerberth L Lindbom 2008 Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages J Clin Invest 118 3491 3502 18787642 10.1172/JCI35740 1:CAS:528:DC%2BD1cXht1ChsrnI
69. S Nuding K Fellermann J Wehkamp HA Mueller EF Stange 2006 A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts J Microbiol Methods 65 335 345 16182394 10.1016/j.mimet.2005.08. 004 1:CAS:528:DC%2BD28Xjs1WlsbY%3D
70. Diamond G, Ryan L. Beta-defensins: what are they REALLY doing in the oral cavity? Oral Dis. 2011 Feb 18 (Epub ahead of print).
71. Y Lai RL Gallo 2009 AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense Trends Immunol 30 131 141 19217824 10.1016/j.it.2008.12.003 1:CAS:528:DC%2BD1MXivVertr8%3D
72. HR Ibrahim U Thomas A Pellegrini 2001 A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action J Biol Chem 276 43767 43774 11560930 10.1074/jbc.M106317200 1:STN:280:DC%2BD3MnnvVCruw%3D%3D
73. WS Jang HK Kim KY Lee SA Kim YS Han IH Lee 2006 Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium FEBS Lett 580 1490 1496 16469314 10.1016/j.febslet.2006.01.041 1:CAS:528:DC%2BD28Xhs1SntLY%3D (Pubitemid 43222020)